Cases

United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued April 17, 2025 Decided September 26, 2025 No. 24-5235 NOVARTIS PHARMACEUTICALS CORPORATION, APPELLANT v. ROBERT F. KENNEDY, JR., IN HIS OFFICIAL CAPACITY AS SECRETARY OF HEALTH AND HUMAN SERVICES, ET AL., APPELLEES Appeal from the United States District Court

Chen, Circuit Judge. This case involves the complicated, potential double-patenting situation in which the later-filed of two related patents, which share a common specification and effective filing date, expires before the term of the earlier-filed patent due to an intervening change in law by Congress defining a patent's term. When the patent owner filed for the first patent, the go

Chen, Circuit Judge. *1369 SUMMARY This case concerns the interplay between a patent term extension (PTE) granted pursuant to 35 U.S.C. § 156

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA NORWICH PHARMACEUTICALS, INC., Plaintiff, Civil Action No. 25-091 v. (BAH) Judge Beryl A. Howell ROBERT F. KENNEDY JR., in his official capacity as Secretary of Health and Human FILED UNDER SEAL Services, et al.,

Case: 12-15548 Date Filed: 02/24/2016 Page: 1 of 113 [PUBLISH] IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT __________________________ No. 12-15548 __________________________ D.C. Docket No. 2:09-cv-

Case: 12-15548 Date Filed: 02/24/2016 Page: 1 of 112 [PUBLISH] IN THE UNITED STATES COURT OF APPEALS FOR THE ELEVENTH CIRCUIT __________________________ No. 12-15548 __________________________ D.C. Docket No. 2:09-cv-

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA JOHNSON & JOHNSON : HEALTH CARE SYSTEMS INC., : : Plaintiff, : Civil Action No.: 24-3188 (RC) : v. : Re Document Nos.:

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA AMGEN, INC, et al., Plaintiffs, v. Civil Action No. 24-3571 (JEB) ROBERT F. KENNEDY JR., et al., Defendants. MEMORANDUM OPINION Section 340B of the Public Health Service Act requires pharmaceutical companies to sell their drugs to certain healthcare providers a

JOHNSON, Senior District Judge: Relators Joseph Piacentile and Kevin B. Kilcoyne bring this qui tam action on behalf of the United States, the District of Columbia and 21 states, alleging, inter alia , that Kilcoyne's former employer, Amgen, Inc. ("Amgen"), and U.S. Oncology, Inc. ("U.S. Oncology" or "Defendant") violated, and conspired to violate, the False Claims Act,

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA JOHNSON & JOHNSON : HEALTH CARE SYSTEMS INC., : Plaintiff, : : v. : : Civil Action No.: 24-3188 (RC) ROBERT F. KENNEDY, JR.,

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA BOARD OF TRUSTEES OF THE : UNIVERSITY OF ALABAMA et al., : : Plaintiffs, : Civil Action No.: 22-3367 (RC) : v. : Re Document Nos.: 17, 18

Filed 5/1/23 CERTIFIED FOR PUBLICATION IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA THIRD APPELLATE DISTRICT (Sacramento) ---- CRESTWOOD BEHAVIORAL HEALTH, INC., C094882 Plaintiff and Appellant, (Super. Ct. No.

KEARNEY, District Judge A television network advertising a show purporting to describe the "true" story of disputed historical events must be careful to not misrepresent the specifics of its show so as to mislead the consumer concerning its product. Summarizing an argument or opinion offered within the show is different than a statement made about a show as a product such as its length, characters or producers. Whe

ORDER AND REASONS JANE TRICHE MILAZZO, District Judge. Before the Court are two Motions filed by Defendants: (1) Motion for Partial Summary Judgment (R. Doc. 242), and (2) Motion in Limine to Exclude Dr. Arthur Sanford (R. Doc. 290). For the following reasons, the Motion for Partial Summary Judgment is GRANTED IN PART. Plaintiffs design defect claim shall remain pending, but only insof

Filed 8/17/21 CERTIFIED FOR PUBLICATION COURT OF APPEAL, FOURTH APPELLATE DISTRICT DIVISION ONE STATE OF CALIFORNIA DEBRA TURNER, D076318, D076337 Plaintiff and Appellant, v. (Super. Ct. Nos. 37-2017- 00009873-PR-TR-CTL; 37-2018- LAURIE ANNE VICTORIA et al.,

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ELI LILLY AND COMPANY, et al., Plaintiffs, v. No. 24-cv-03220 (DLF) ROBERT F. KENNEDY JR., et al., Defendants, and 340B HEALTH, et al., Intervenor-Defendants. BRISTOL MYERS SQUIBB COMPANY, Plaintiff, v. No. 24-cv-03337 (DLF) ROBERT F. KENNEDY

Opinion and Order WILLIAM K. SESSIONS III, District Judge. Plaintiff J.D. is a minor whose parents, Kevin and Lori Drake, filed claims individually and as next friend of J.D. against Defendant Allergan, Inc. (“Allergan”), the manufacturer of Botox. J.D. has cerebral palsy. His doctor injected Botox into his calves to treat his lower limb spasticity. The Plaintiffs claimed that these injections

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) SUN PHARMA ADVANCED ) RESEARCH CO., LTD., et al., ) ) Plaintiffs, ) ) v. )

Justice GREEN delivered the Opinion of the Court. Under the learned intermediary doctrine, the manufacturer of a pharmaceutical product satisfies its duty to warn the end user of its product’s potential risks by providing an adequate warning to a “learned intermediary,” who then assumes the duty to pass on the necessary warnings to the end user. See, e.g., Gravis v. Parke-Davis & Co., 502 S.W.2d

Filed 4/2/20 CERTIFIED FOR PARTIAL PUBLICATION* IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA THIRD APPELLATE DISTRICT (Placer) ---- ROBERT WEIMER, JR., C080550 Plaintiff and Appellant, (Super. Ct. No. SCV0035286) v. NATIONSTAR MO